LungLife AI (LSE:LLAI) Market Cap : £5.83 Mil (As of May. 27, 2024)

View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). LungLife AI's share price for the quarter that ended in Dec. 2023 was £0.46. LungLife AI's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 25.49 Mil. Therefore, LungLife AI's market cap for the quarter that ended in Dec. 2023 was £11.72 Mil.

LungLife AI's quarterly market cap declined from Dec. 2022 (£21.66 Mil) to Jun. 2023 (£6.50 Mil) but then increased from Jun. 2023 (£6.50 Mil) to Dec. 2023 (£11.72 Mil).

LungLife AI's annual market cap declined from Dec. 2021 (£47.90 Mil) to Dec. 2022 (£21.66 Mil) and declined from Dec. 2022 (£21.66 Mil) to Dec. 2023 (£11.72 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. LungLife AI's Enterprise Value for Today is £3.87 Mil.

LungLife AI Market Cap Historical Data

The historical data trend for LungLife AI's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI Market Cap Chart

LungLife AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

47.90

21.66

11.72

LungLife AI Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial					47.90	36.95	21.66	6.50	11.72

Competitive Comparison of LungLife AI's Market Cap

For the Diagnostics & Research subindustry, LungLife AI's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LungLife AI's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LungLife AI's Market Cap distribution charts can be found below:

* The bar in red indicates where LungLife AI's Market Cap falls into.

LungLife AI Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

LungLife AI's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	£0.46	*	25.486
	=	£11.72

LungLife AI's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	£0.46	*	25.486
	=	£11.72

LungLife AI (LSE:LLAI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

LungLife AI Market Cap Related Terms

Thank you for viewing the detailed overview of LungLife AI's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

LungLife AI (LSE:LLAI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320

Website

https://www.lunglifeai.com

LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.

LungLife AI (LSE:LLAI) Headlines

No Headlines